Traders bought shares of CVS Health Corporation (NYSE:CVS) on weakness during trading hours on Thursday. $141.44 million flowed into the stock on the tick-up and $70.10 million flowed out of the stock on the tick-down, for a money net flow of $71.34 million into the stock. Of all equities tracked, CVS Health Corporation had the 2nd highest net in-flow for the day. CVS Health Corporation traded down ($0.17) for the day and closed at $97.46

A number of brokerages have issued reports on CVS. Credit Suisse Group AG reissued a “buy” rating and set a $115.00 target price on shares of CVS Health Corporation in a report on Sunday, June 5th. Zacks Investment Research cut shares of CVS Health Corporation from a “hold” rating to a “sell” rating in a report on Monday, April 18th. Vetr raised shares of CVS Health Corporation from a “hold” rating to a “buy” rating and set a $113.29 target price on the stock in a report on Monday, April 4th. Jefferies Group reissued a “buy” rating on shares of CVS Health Corporation in a report on Monday, July 4th. Finally, Morgan Stanley reissued a “buy” rating on shares of CVS Health Corporation in a report on Thursday, April 7th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, seventeen have assigned a buy rating and two have given a strong buy rating to the stock. CVS Health Corporation currently has an average rating of “Buy” and a consensus price target of $113.72.

The company has a market capitalization of $104.28 billion and a P/E ratio of 21.10. The stock has a 50-day moving average price of $95.68 and a 200-day moving average price of $98.34.

CVS Health Corporation (NYSE:CVS) last issued its quarterly earnings data on Tuesday, May 3rd. The pharmacy operator reported $1.18 EPS for the quarter, topping analysts’ consensus estimates of $1.16 by $0.02. The business earned $43.20 billion during the quarter, compared to analysts’ expectations of $43.01 billion. The business’s quarterly revenue was up 18.9% on a year-over-year basis. During the same period in the previous year, the business earned $1.14 earnings per share. On average, analysts anticipate that CVS Health Corporation will post $5.83 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, August 1st. Shareholders of record on Thursday, July 21st will be paid a $0.425 dividend. The ex-dividend date of this dividend is Tuesday, July 19th. This represents a $1.70 dividend on an annualized basis and a dividend yield of 1.75%.

In related news, CEO Larry J. Merlo sold 38,247 shares of CVS Health Corporation stock in a transaction dated Thursday, May 5th. The shares were sold at an average price of $105.00, for a total transaction of $4,015,935.00. Following the completion of the transaction, the chief executive officer now directly owns 280,381 shares of the company’s stock, valued at approximately $29,440,005. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Troyen A. Brennan sold 7,517 shares of CVS Health Corporation stock in a transaction dated Thursday, May 5th. The stock was sold at an average price of $105.00, for a total transaction of $789,285.00. Following the transaction, the executive vice president now directly owns 69,601 shares of the company’s stock, valued at $7,308,105. The disclosure for this sale can be found here.

Other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in CVS Health Corporation by 1.6% in the fourth quarter. Vanguard Group Inc. now owns 68,950,833 shares of the pharmacy operator’s stock worth $6,741,323,000 after buying an additional 1,086,137 shares in the last quarter. Morgan Stanley boosted its position in CVS Health Corporation by 12.8% in the fourth quarter. Morgan Stanley now owns 11,485,756 shares of the pharmacy operator’s stock worth $1,122,961,000 after buying an additional 1,304,751 shares in the last quarter. Wells Fargo & Company MN boosted its position in CVS Health Corporation by 3.1% in the fourth quarter. Wells Fargo & Company MN now owns 10,271,213 shares of the pharmacy operator’s stock worth $1,004,217,000 after buying an additional 313,389 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in CVS Health Corporation by 8.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 8,937,908 shares of the pharmacy operator’s stock worth $873,912,000 after buying an additional 689,609 shares in the last quarter. Finally, Bank of Montreal Can boosted its position in CVS Health Corporation by 0.4% in the fourth quarter. Bank of Montreal Can now owns 4,967,220 shares of the pharmacy operator’s stock worth $485,648,000 after buying an additional 19,949 shares in the last quarter.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.